93 5361 (Ursodiol 500 mg)
Pill imprint 93 5361 has been identified as Ursodiol 500 mg.
Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 93 5361
- Strength:
- 500 mg
- Color:
- White
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-5361
- Inactive Ingredients:
- cetyl alcohol
silicon dioxide
dibutyl sebacate
ethylcellulose (10 mPa.s)
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol 6000
polyethylene glycol 3350
povidone k90
sodium lauryl sulfate
sodium starch glycolate type A potato
More about ursodiol
Consumer resources
- Other brands: Actigall, Urso, Urso Forte
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
